DacopafantAlternative Names: RP 55778
Latest Information Update: 24 Jun 2002
At a glance
- Originator Aventis
- Class Antiasthmatics; Antivirals; Small molecules
- Mechanism of Action Platelet activating factor inhibitors; Tumour necrosis factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Suspended Asthma; Systemic inflammatory response syndrome
- No development reported HIV infections